AZU1
Azurocidin
Also known as: AZAMP, AZU, CAP37, CAP7_HUMAN, HBP, HUMAZUR, NAZC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20160
- Gene
- AZU1
- Ensembl
- ENSG00000172232
- Chromosome
- 19
- Canonical length
- 251 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Azurophil granules, specialized lysosomes of the neutrophil, contain at least 10 proteins implicated in the killing of microorganisms. This gene encodes a preproprotein that is proteolytically processed to generate a mature azurophil granule antibiotic protein, with monocyte chemotactic and antimicrobial activity. It is also an important multifunctional inflammatory mediator. This encoded protein is a member of the serine protease gene family but it is not a serine proteinase, because the active site serine and histidine residues are replaced. The genes encoding this protein, neutrophil elastase 2, and proteinase 3 are in a cluster located at chromosome 19pter. All 3 genes are expressed coordinately and their protein products are packaged together into azurophil granules during neutrophil differentiation. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
251 residues, UniProt reviewed canonical sequence.
>P20160|AZU1
1 MTRLTVLALL AGLLASSRAG SSPLLDIVGG RKARPRQFPF LASIQNQGRH FCGGALIHAR
61 FVMTAASCFQ SQNPGVSTVV LGAYDLRRRE RQSRQTFSIS SMSENGYDPQ QNLNDLMLLQ
121 LDREANLTSS VTILPLPLQN ATVEAGTRCQ VAGWGSQRSG GRLSRFPRFV NVTVTPEDQC
181 RPNNVCTGVL TRRGGICNGD GGTPLVCEGL AHGVASFSLG PCGRGPDFFT RVALFRDWID
241 GVLNNPGPGP ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against AZU1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 1,508 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 1,508 nTPM
- spleen: 33 nTPM
- lung: 16 nTPM
- thymus: 2.8 nTPM
- liver: 2.6 nTPM
- cerebral cortex: 2.3 nTPM
Single-cell type
- neutrophil progenitors: 473 nCPM
- monocyte progenitors: 424 nCPM
- undifferentiated spermatogonia: 6.9 nCPM
- erythrocytes: 4.4 nCPM
- fallopian tube ciliated cells: 3 nCPM
- monocytes: 2.7 nCPM
Immune cell
- neutrophil: 3.3 nTPM
- myeloid DC: 0.3 nTPM
- eosinophil: 0.2 nTPM
- non-classical monocyte: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 0.9 nTPM
- thalamus: 0.8 nTPM
- basal ganglia: 0.7 nTPM
- pons: 0.7 nTPM
- amygdala: 0.6 nTPM
- hippocampal formation: 0.6 nTPM
ReferencesPubMed · IEDB
Publications for AZU1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis.
1996 · Clin Exp Immunol · RCR 1.1 · 34 citations - Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease.
1996 · Clin Exp Immunol · RCR 1 · 26 citations - Pyoderma gangrenosum, polyarthritis and lung cysts with novel antineutrophil cytoplasmic antibodies to azurocidin.
1998 · Br J Dermatol · RCR 0.4 · 7 citations - Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura.
2012 · Br J Dermatol · RCR 0.4 · 13 citations - [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
2003 · Zhonghua Yi Xue Za Zhi · RCR 0.1 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral response
- cell chemotaxis
- cellular extravasation
- defense response to Gram-negative bacterium
- defense response to virus
- glial cell migration
- induction of positive chemotaxis
- inflammatory response
- intracellular signal transduction
- macrophage chemotaxis
- microglial cell activation
- monocyte activation
- monocyte extravasation
- negative regulation of apoptotic process
- neutrophil-mediated killing of bacterium
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of cell adhesion
- positive regulation of fractalkine production
- positive regulation of interleukin-1 beta production
- positive regulation of MHC class II biosynthetic process
- positive regulation of phagocytosis
- positive regulation of tumor necrosis factor production
- protein maturation
- proteolysis
- regulation of vascular permeability
Molecular functions
- heparan sulfate proteoglycan binding
- heparin binding
- peptidase activity
- serine-type endopeptidase activity
- toxic substance binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AZU1 as an antibody target. Whether an autoantibody or antibody against AZU1 could matter depends on whether native AZU1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AZU1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AZU1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...